AU2013203194B9 - Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione - Google Patents

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Info

Publication number
AU2013203194B9
AU2013203194B9 AU2013203194A AU2013203194A AU2013203194B9 AU 2013203194 B9 AU2013203194 B9 AU 2013203194B9 AU 2013203194 A AU2013203194 A AU 2013203194A AU 2013203194 A AU2013203194 A AU 2013203194A AU 2013203194 B9 AU2013203194 B9 AU 2013203194B9
Authority
AU
Australia
Prior art keywords
isoindol
dione
piperidine
dihydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013203194A
Other versions
AU2013203194A1 (en
AU2013203194B2 (en
Inventor
Louise M Cameron
Roger Shen-Chu Chen
Markian S Jaworsky
George W. Muller
Manohar T. Saindane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012200259A external-priority patent/AU2012200259C1/en
Application filed by Celgene Corp filed Critical Celgene Corp
Priority to AU2013203194A priority Critical patent/AU2013203194B9/en
Publication of AU2013203194A1 publication Critical patent/AU2013203194A1/en
Publication of AU2013203194B2 publication Critical patent/AU2013203194B2/en
Application granted granted Critical
Publication of AU2013203194B9 publication Critical patent/AU2013203194B9/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013203194A 2003-09-04 2013-04-09 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione Ceased AU2013203194B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013203194A AU2013203194B9 (en) 2003-09-04 2013-04-09 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/499,723 2003-09-04
AU2012200259A AU2012200259C1 (en) 2003-09-04 2012-01-16 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
AU2013203194A AU2013203194B9 (en) 2003-09-04 2013-04-09 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2012200259A Division AU2012200259C1 (en) 2003-09-04 2012-01-16 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Publications (3)

Publication Number Publication Date
AU2013203194A1 AU2013203194A1 (en) 2013-05-02
AU2013203194B2 AU2013203194B2 (en) 2015-12-03
AU2013203194B9 true AU2013203194B9 (en) 2016-01-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP3045176B8 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydroisoindol-2-yl)-piperidine-2,6-dione
IL190437A0 (en) Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
AU2013203194B9 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione